Dr. Sanjay Khanna
Medical Oncology Registrar & Pharmaceutical Physician.
Dually trained in clinical practice and pharmaceutical strategy. My work synthesizes patient-facing AI, behavioural science, and health policy to design 21st-century cancer care systems.
My Research
My work synthesizes four distinct areas. Click a tile to jump to the relevant publications.
View All Publications on Google Scholar01. Patient-Facing AI
Benchmarking LLMs (Gemini) for safety, empathy, and hallucination in clinical settings.
02. Policy & Regulation
Comparative analysis of FDA/EMA approvals and the impact of Brexit on UK oncology access.
03. Equity & Access
Identifying barriers to clinical trial recruitment in ethnic minority groups.
04. Clinical Science
Applied research in Haematology-Oncology, ECMO, and Thrombocytopenia.
01. Patient-Facing AI & Safety
- Instructed Large Language Models as a Decision-Aid Tool for Lung Cancer Screening Participants Performance and Exploration of LLM-Powered Quality Assessment in the UK setting.
- Performance of Publicly Available Large Language Models as Decision-Aids for Lung Cancer Screening An Evaluation of Quality, Safety, and Readability of models including Gemini and GPT-4.
02. Policy & Regulation
- Access to Oncology Drugs in the UK – Are we falling behind Europe after Brexit? A retrospective analysis of regulatory performance and reimbursement for oncology drugs, highlighting infrastructure gaps.
- Regulatory approvals for genitourinary (GU) cancer by the FDA and EMA over 20 years Comparative analysis of regulatory timelines and approval divergence (2003-2023).
03. Equity & Access
- Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups A systematic review identifying structural and cultural barriers to equitable trial recruitment.
- A mixed-methods study on the recruitment of patients from ethnic minority groups to clinical trials Real-world data analysis from a central London teaching hospital.
04. Clinical Science
- Frequency of thrombocytopenia and heparin-induced thrombocytopenia in patients receiving ECMO High-impact study on coagulation complications in extracorporeal membrane oxygenation.
- Primary Effusion Lymphoma: a single-institution cohort study Clinical cohort analysis of rare lymphoma presentations.
- Antibody-Drug Conjugates in Genitourinary Malignancies The Clinical Trial Landscape and Emerging Efficacy Benchmarks.
Blog
Reflections on AI in healthcare, oncology policy, and the future of medicine.
Coming Soon
I'm working on articles about AI safety in oncology, health policy reform, and the physician-scientist journey.
Subscribe to be notified when new posts are published:
Strategic Leadership
System & Strategy
Experience in leveraging clinical data to influence national policy frameworks. I focus on ensuring national infrastructure is prepared for the next generation of screening and AI technologies.
Operational leadership in large-scale trials (80,000+ participants). Bridging commercial strategy and clinical reality to minimise burden and maximise uptake.
3 years as Portfolio Mentor at Start Codon. Evaluated startups on regulatory viability and clinical fit, not just technology.
Clinical & Academic
Medical Oncology Registrar & Pharmaceutical Physician. I possess a rare "bilingual" ability to translate between clinical teams and commercial/policy stakeholders.
Expertise in designing studies that satisfy both regulatory requirements (MHRA/FDA) and payer requirements (NICE/HTA).
Building psychological safety in high-stakes environments to allow teams to challenge the status quo and solve complex patient problems.
Clinical Training
Available for collaboration, advisory, and consulting.
Get in Touch© 2026 Dr. Sanjay Khanna. London.